Merck: This Cancer-Drug Powerhouse Could Be a Core Dividend
A dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
Using Budget Calculator Findings For Financial Planning
Findings from the Budget Calculator guide you in prioritizing goals and shaping a realistic plan. Use them to steer your financial journey.
20,466 articles
Capricorn Dumps 1.19 Million Navitas Shares
Capital moves matter. Capricorn Investment Group reduced its Navitas Semiconductor stake by about 1.19 million shares...
Monster Stocks Hold Next: 3 Big Picks for the Next Decade
In a world leaning toward heavy hardware and intelligent systems, you can find durable franchises that may pay off fo...
Supermicro’s Co-Founder Arrested Over GPU Export Scheme
U.S. authorities charged Supermicro co-founder Yih-Shyan Liaw and two associates with orchestrating a multi-billion-d...
Biocryst (BCRX) 2026 Earnings: What Investors Should Know
BioCryst faces a pivotal year. This practical guide breaks down what biocryst (bcrx) 2026 earnings could mean for inv...
Forget Your Savings Account? Three Monthly Dividend ETFs Pay More
Investors are shifting from traditional savings toward monthly dividend ETFs offering higher yields. This report brea...
How Much Invested to Replace $50K with REIT Income
A $50,000 retirement target split 50/50 between REIT dividends and stock dividends changes the math. Today, investors...
Mark Zuckerberg Meta Predicts Bitcoin Price for Summer 2026
Meta AI projects a Bitcoin breakout by summer 2026, with targets near or above $100K. The call hinges on technical se...
Cramer Says Nokia Back: From Smartphone Casualty to AI Edge
Jim Cramer reframes Nokia’s story from a smartphone casualty to an AI infrastructure play, highlighting the stock’s s...
Dividend Safety Check: International Small-Cap Value ETFs
Investors are weighing DISV and ISVL for international small-cap value exposure, focusing on whether their dividend s...
Reasons Bristol Myers Squibb Stock: 3 Key Arguments
Want to know if Bristol Myers Squibb is worth a spot in your portfolio? This deep dive highlights three core reasons ...
Forget Chipmakers. 0.47% This Fund Owns Data Center Builders
A new ETF strategy shifts focus from AI chipmakers to the data-center buildout, charging 0.47% and backing the compan...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status